Evidence map›Paper›PMID 38659251›Full record

Trial reportThe Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi2024

Comparison of the Efficacy of 12-day Concomitant Quadruple Therapy versus 14-day High dose Dual Therapy as a First-line

Seyed Mohammad Valizadeh Toosi, Sahar Feyzi, Arash Kazemi

Open access · goldAbstract readRandomized Controlled TrialComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Trial report in The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it, 4 citations in OpenAlex.

  1. [Evidence-Based Guidelines for the Diagnosis and Treatment ofThe Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2026
    Guideline
  2. Guideline
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Seyed Mohammad Valizadeh ToosiGut and Liver Research Center, Non-communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.ORCID 0000-0003-3217-4753
Sahar FeyziMedicine faculty, Mazandaran University of Medical Sciences, Sari, Iran.
Arash KazemiGut and Liver Research Center, Non-communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Mazandaran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background/Aims: Methods: In this RCT, we assigned 223 patients with Results: Conclusions: Twelve-day concomitant therapy seems to be an acceptable regimen for first-line

Indexed as

AmoxicillinAnti-Bacterial AgentsClarithromycinDrug Therapy, CombinationEsomeprazoleHelicobacter InfectionsHelicobacter pyloriMetronidazoleAdultAgedDrug Administration ScheduleFemaleHumansMaleMiddle AgedPantoprazoleAmoxicillinAnti-Bacterial AgentsClarithromycinEsomeprazoleMetronidazolePantoprazoleProton Pump InhibitorsConcomitant quadruple therapyEradicationHigh dose dual therapyH. pylori

Identifiers

PMID38659251
PMCPMC12093993
OpenAlexW4395462873

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.